Buy Novus Therapeutics Stock | TKAI Stock Price & Latest News | Public.com
TKAI

Novus Therapeutics

    We couldn’t load this chart.

    Some stock charts might currently not be supported. To try again, please refresh this page.

    View Novus Therapeutics (TKAI) stock trends here

    About TKAI

    Eledon Pharmaceuticals, Inc. engages in the research and development of pharmaceutical products for patients with disorders of the ear, nose, and throat. The company operates under the surfactant and foam platforms. The surfactant platform develops a treatment option fo...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -1.84
    -3.68
    -5.52
    Q2 2020
    Q3 2020
    Q4 2020
    Q1 2021

    Expected EPS
    Q1 2021

    -$0.32

    Actual EPS
    Q1 2021

    Stats

    Market Cap$14,96M
    Volume41,08k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$27.32
    1 Year Low$4.50
    Open$14.84
    High$14.84
    Low$13.59

    Buy any stock with any amount of money.

    Download the App
    Download the app